A case of an 18-year-old man with deep venous thrombosis of the lower limbs caused by hypoplasia of the inferior vena cava in combination with heterozygous factor V Leiden is presented. Both anomalies were found when the patient complained of venous claudication in both thighs. Inferior vena cava malformation is a rare condition and may predispose to the development of deep venous thrombosis. This patient was at an even higher risk for deep venous thrombosis as the inferior vena cava malformation was combined with a hypercoagulable state.
Introduction
Congenital anomalies of the inferior vena cava (IVC) such as atresia or hypoplasia are rare vascular defects. It becomes usually apparent in childhood if a defect is combined with congenital anomalies of the heart, polysplenia, and/or bowel inversion. Although it is likely to induce venous stasis, patients without associated conditions remain usually asymptomatic because associated azygous, hemiazygos or portal continuation develops as a collateral pathway for venous return. Deep venous thrombosis (DVT) has a multifactorial etiology involving both genetic and acquired factors by inducing venous stasis or a state of hypercoagulability. A combination of predisposing factors greatly increases the risk of developing DVT. We describe an 18-year old patient with hypoplasia of the inferior vena cava and azygos continuation in combination with heterozygous factor V Leiden causing DVT in the lower limbs presented with venous claudication. Clinical, diagnostic and therapeutic features are discussed.
Case Report
An 18-year-old law student presented to our emergency department with a 10-day history of progressive pain and contractures of both thighs and of the sacroiliac region after a few meters walking. He had been in good health before the onset of the symptoms, and his medical history included surgery for bowel duplication at the age of 9 and an occasional consumption of cannabis. He also pointed out he had had recent extensive immobilization during school examinations.
Examination of the lungs, heart, and abdomen was normal and all peripheral arterial pulses were present. Diminished force of the quadriceps muscles was remarked. No signs of acute DVT were present. Laboratory findings showed no increase in white blood cells, a C-reactive protein at 19.8 mg/dL, and a blood sedimentation rate at 83 mm in 1 hour.
A chest radiograph showed an enlarged azygos arch, first mistaken for an enlarged right-sided paratracheal adenopathy.
Arterial and venous examination with Doppler ultrasound of the lower limbs and the abdomen revealed a complete thrombosis of the IVC at infrarenal level as well as of iliac and femoral veins of both legs. No abnormalities were found under knee-level. Contrast-enhanced tomodensitometry of the thorax, the abdomen, and the lower limbs showed similar results as well as hypoplasia of the inferior vena cava at suprarenal and retrohepatic level, azygos continuation, and an enlarged diameter of the left hemiazygos. No other visceral anomalies were found except duplication of the right renal artery (Figures 1-4 ) and pulmonary embolism was excluded. The treatment initiated immediately consisted of bed rest and intravenous anticoagulation with heparin (5000 IU bolus followed by 400 IU/kg for 24 hours). The patient was admitted for further examinations including research of thrombophilic conditions. Findings revealed resistance to activated protein C (APC) and elevated D-dimer levels at 7960 ng/mL (normal < 500 ng/mL). Other results were within normal range. Further molecular investigations showed a heterozygous factor V Leiden mutation. Firstdegree relatives were also tested for thrombophilic conditions. His mother and his brother were also found to be resistant to APC, although none had developed DVT. No further genetic investigations were performed. The patient was discharged with oral anticoagulation (acenocoumarol), which was discontinued 2 years after the initial episode. No new episode of DVT had occurred and control CT scanner and ultrasound showed sufficient compensatory venous return through the epigastric and the lumbar paravertebral veins ( Figure 5 ). There still was no recurrence 6 months after ending therapy.
Discussion
During embryogenesis, the IVC is formed by a process involving the development, regression, and anastomosis of 3 sets of paired veins: the posterior cardinal, subcardinal, and supracardinal veins. The normal IVC is converted to a unilateral right-sided system consisting, from cranium to cauda, of the hepatic, prerenal, renal, and postrenal segments. 1 Developmental failures can result in a hypoplastic hepatic segment or total absence of this segment. [1] [2] [3] The causal reasons of this failure are unclear. Hypotheses are either embryonic dysontogenesis that affects different segments or the entire IVC causing intrauterine thrombosis or umbilical vein complication postpartum. 4 There can be an association with congenital malformation of abdominal viscera such as polysplenia, asplenia, situs inversus, and others. Usually, those patients are diagnosed early in life. However, patients without visceral anomalies may remain asymptomatic if a deep venous collateral system exists, returning blood from to lower extremities to the heart through the azygos and hemiazygos veins (azygos continuation).
The incidence of IVC abnormalities is 0.6% to 2.0% in individuals with congenital heart malformations and less than 0.3% in individuals without any other variations or anomalies. 5 The prevalence in the general population lies between 0.07% and 8.7% 6 but could be underestimated because the vascular defect is often reported as a fortuitous finding during surgery or radiological investigations for other reasons. Deep venous thrombosis in the young age may be a complication of this rare congenital abnormality. 7, 8 Genetic factors predisposing to thrombophilia in coincidence with vena cava malformation put the patients at much higher risk to develop thrombosis. Our patient showed resistance to activated protein C (APCR). Normally, APC inactivates factors Va and VIIIa in the presence of free protein S and phospholipids, thereby inhibiting the generation of thrombin. Mutation of the factor V gene (factor V Leiden) leads to resistance and thereby increases the generation of thrombin. 9 In inherited conditions associated with hypercoagulability, which predispose to DVT, the defect is lifelong and yet thrombosis is rarely seen in children less than 16 years. 7 Often in these individuals, an additional acquired prothrombotic event is documented, although in some cases age alone is identified as the additional risk factor. 7,10 Prolonged immobilization, an acquired risk factor, most certainly contributed to the formation of the thrombosis in our patient. Curiously, strenuous exertion has sometimes been reported as the prothrombotic event. 11, 12 Clinical presentation varies depending on the extent of the thrombosis and the recognition of the underlying pathology. Venous claudication is defined as the presence of thigh/leg pain and tightness on exercise which subsides with rest and is a sign of chronic venous disease. 13 Together with recurrent DVT, it is the most common clinical presentation of IVC anomalies. 7 Other presentations such as leg ulceration due to venous stasis or a condition mimicking an aortic pathology have been reported. 14, 15 As reported in the literature, ultrasonography (US), which is the procedure of choice in case of suspected DVT, failed to detect the abnormality. 16 Ultrasonography can suggest the diagnosis but may be limited by technical factors and in the assessment of the whole inferior vena cava. 17 An enlarged azygos arch can readily be mistaken for a mediastinal mass or aortic dissection. 15 Appropriate imaging studies are computed tomographic (CT) scan or magnetic resonance (MR) tomography. 16, 18, 19 Phlebography remains the most accurate diagnostic method but has the disadvantage of being invasive and is not always feasible, especially in the presence of a more distal thrombosis. There are no data available on the management of DVT associated with IVC anomalies. Several studies have shown that thrombolytic agents, even when administered systemically, are superior to standard anticoagulation therapy in achieving early thrombolysis in patients with idiopathic DVT. Long-term effects of DVT such as postthrombotic syndrome can be avoided when lysis is achieved, due to preservation of valve function. 20 We did not perform thrombolysis. Although the actual time of occlusion could not accurately be determined, the symptoms and the imagery suggested it was not acute.
Since our patient presents 2 risk factors, we opted for long-term oral anticoagulation with acenocoumarol (Sintrom) within a therapeutic international normalized ratio (INR) of 2 to 3. We also advised the patient to avoid prolonged immobilization and unusual physical activity.
About 2 years after the initial episode, the patient spontaneously stopped oral anticoagulation and 6 months later, no new episode of DVT or venous claudication had occurred, and control CT scanner and ultrasound showed sufficient compensatory venous return through the epigastric and the lumbar paravertebral veins ( Figure 5 ). As this compensation was enough to avoid recurrence and late complications were uncertain, we advised the patient to restart his treatment.
Open reconstructive vascular surgery may be indicated in patients having debilitating complications due to chronically occluded IVC and iliofemoral veins 14, 21 although several studies have shown encouraging results with endoluminal recanalization and stent placement in chronically thrombosed venous segments. 20, 22, 23 The review of the literature revealed that the vena cava malformation in association with a genetic factor predisposing to thrombophilia is an infrequent condition.
We conclude that it is essential to perform the relevant molecular genetic investigations to identify the presence of thrombophilic vulnerability and radiological imaging procedures in all cases of young patients with idiopathic deep venous thrombosis. Therapy should be focused on the prevention of thrombosis. We recommend lifelong oral anticoagulation in any case of DVT caused by IVC abnormalities especially in the presence of other risk factors, although further studies are required to evaluate the optimal duration of the treatment in this kind of patient. Thrombolysis could be considered if the thrombosis is acute. Open or endovascular surgery may be indicated for recurrent, complicated, and nonresponsive cases.
